Categories
Bad science Bioethics Clinical trials Medicine Politics Popular culture Pseudoscience

Drs. Vladimir Zelenko and Stephen Smith: Abandoning evidence-based medicine to promote unproven drugs for COVID-19

Drs. Vladimir Zelenko and Stephen Smith have been claiming that hydroxychloroquine is a miracle drug based on anecdotes. Their shoddy, poorly reported case series are not evidence of efficacy.

Categories
Bad science Clinical trials Medicine Politics Popular culture Skepticism/critical thinking

The FDA’s emergency use authorization of chloroquine and hydroxychloroquine for COVID-19: Dangerous politics, not science

Yesterday, the FDA issued emergency use authorization for hydroxychloroqine and chloroquine to treat COVID-19. Politics, not science, is why.

Categories
Antivaccine nonsense Medicine Politics Pseudoscience Religion

The latest attempt by the antivaccine movement to use religion to oppose school vaccine mandates

Antivaxxers frequently claim that their objection to vaccines is based on their religion. Another attempt to frame opposition to school vaccine mandates as religious freedoms is making the rounds.

Categories
Antivaccine nonsense Bad science Computers and social media Medicine Quackery

Mike Adams banned from Facebook: Griftus interruptus

Mike Adams has been a peddler of conspiracy theories for over 20 years. Over the weekend Facebook banned him, interrupting the grift, at least somewhat.

Categories
Bad science Bioethics Medicine Politics Popular culture Quackery

The cruel sham that is federal right-to-try has passed. Let patients beware!

“Right-to-try” laws are a cruel sham that purport to allow terminally ill patients access to promising experimental drugs. In reality, they strip away many protections and leave vulnerable patients on their own. After four years and a number of toothless state laws, a federal version of “right-to-try” has passed Congress and is poised to become law. Once President Trump signs the bill this week, this federal version of “right-to-try” will leave terminally ill patients on their own and will likely be the first step in returning the FDA to its pre-thalidomide state, in which it only required evidence of safety, not efficacy, to approve drugs.